{
 "drug": "Adalimumab-afzb Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/09/2025",
 "dayN": 320,
 "cat": "Rheumatology",
 "companies": [
  "Pfizer Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/09/2025",
   "update_type": "New",
   "initial_posting_date": "10/09/2025",
   "package_ndc": "0025-0325-01",
   "generic_name": "Adalimumab-afzb Injection",
   "contact_info": "800-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "BLA761118"
    ],
    "brand_name": [
     "ABRILADA"
    ],
    "generic_name": [
     "ADALIMUMAB-AFZB"
    ],
    "manufacturer_name": [
     "Pfizer Laboratories Div Pfizer Inc"
    ],
    "product_ndc": [
     "0025-0325",
     "0025-0328",
     "0025-0333",
     "0025-0347",
     "0025-0319"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "rxcui": [
     "797544",
     "2668064",
     "2668071",
     "2668074",
     "2668078",
     "2668095",
     "2668096",
     "2668105",
     "2668106",
     "2668109",
     "2668113"
    ],
    "spl_id": [
     "0989d777-c225-46a6-854e-01bdf4f19679"
    ],
    "spl_set_id": [
     "5ef1c7cf-466f-495e-8d13-82e2ddfa7a4f"
    ],
    "package_ndc": [
     "0025-0325-01",
     "0025-0325-02",
     "0025-0318-01",
     "0069-1111-01",
     "0025-0328-01",
     "0025-0328-02",
     "0025-0317-01",
     "0025-0333-02",
     "0025-0329-01",
     "0025-0347-02",
     "0025-0331-01",
     "0025-0319-01"
    ]
   },
   "update_date": "10/09/2025",
   "therapeutic_category": [
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Abrilada, Injection, Kit (NDC 0025-0325-01)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  }
 ]
}